2477 studies found for:    "Hepatitis"
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Completed Epidemiological Study in Children and Adolescents With Chronic Hepatitis B
Conditions: Liver Diseases;   Hepatitis, Chronic;   Hepatitis, Viral, Human;   Hepatitis;   Virus Diseases;   Digestive System Diseases;   Hepatitis B, Chronic;   Hepatitis B;   DNA Virus Infections
Intervention:
2 Completed
Has Results
Lamivudine and Adefovir to Treat Chronic Hepatitis B
Conditions: HBV (Hepatitis B Virus);   Hepatitis B;   Hepatitis
Interventions: Drug: Lamivudine and adefovir;   Drug: Adefovir alone
3 Recruiting Non-invasive Biomarkers of Fibrosis in Pediatric Viral Hepatitis
Conditions: Viral Hepatitis;   Liver Fibrosis;   Liver Disease;   Hepatitis B;   Hepatitis C
Intervention:
4 Unknown  Differential Gene Expression of Liver Tissue and Blood From Individuals With Chronic Viral Hepatitis
Conditions: Hepatitis C;   Hepatitis B;   Autoimmune Hepatitis;   Liver Cirrhosis, Biliary;   Cholangitis, Sclerosing
Intervention:
5 Terminated Randomized Placebo-controlled Trial Evaluating the Safety and Efficacy of Silymarin Treatment in Patients With Acute Viral Hepatitis
Conditions: Acute Hepatitis A;   Acute Hepatitis B;   Acute Hepatitis C;   Acute Hepatitis E;   Acute EBV Hepatitis;   Acute CMV Hepatitis
Interventions: Dietary Supplement: Silymarin;   Other: Lactose monohydrate
6 Enrolling by invitation A Study to Evaluate the Safety and Effect of Treatment With Experimental Antiviral Drugs in Combination With Peginterferon Alpha-2a and Ribavirin in People With Hepatitis C Virus Who Did Not Respond to Treatment in a Previous AbbVie/Abbott Combination Study
Conditions: Chronic Hepatitis C;   Hepatitis C (HCV);   Hepatitis C Genotype 1
Interventions: Drug: ABT-450/r;   Drug: ABT-267;   Drug: pegylated interferon alpha-2a (pegIFN);   Drug: Ribavirin (RBV)
7 Recruiting New Treatment Response in People With and Without Cirrhosis From Chronic Hepatitis C
Conditions: Cirrhosis;   Chronic Hepatitis C;   Hepatitis C;   Hepatitis C, Chronic
Interventions: Drug: Asunaprevir and Daclatsvir;   Drug: Asunaprevir, daclatsvir, peginterferon, ribavirin
8 Completed Lamivudine for Chronic Hepatitis B
Conditions: Chronic Hepatitis B;   Chronic Hepatitis D;   Glomerulonephritis;   Polyarteritis Nodosa
Intervention: Drug: Lamivudine
9 Completed Investigation of Hepatitis B and Hepatitis C in Taiwan
Conditions: Hepatitis B;   Hepatitis C
Intervention: Biological: blood sampling and abdominal sonography
10 Completed Hepatitis B Virus Reactivation After Withdrawal of Prophylactic Antiviral Therapy in Lymphoma Patients
Conditions: Hepatitis;   Hepatitis B;   Lymphoma;   Hematologic Diseases
Intervention:
11 Completed Birth-Cohort Evaluation to Advance Screening and Testing for Hepatitis C
Conditions: Hepatitis C;   Chronic Hepatitis C
Interventions: Other: Mailer;   Other: In-person recruitment;   Other: EHR Alert
12 Terminated Monotherapy Versus Placebo Over 14 or 17 Days in Healthy and Hepatitis C Infected Adults
Conditions: Hepatitis C, Chronic;   Hepatitis C
Intervention: Drug: GSK625433/placebo
13 Withdrawn Maraviroc Versus Etravirine In Combination With Antiretroviral Therapy In Drug Experienced HIV And Hepatitis Co-Infected Patients
Conditions: Hepatitis B;   Human Immunodeficiency Virus;   Hepatitis C, Chronic
Interventions: Drug: maraviroc;   Drug: etravirine
14 Completed Effect of Risk Factors Likely to Influence Immuno of Combined Hepatitis A & B Vacc vs Monovalent Hepatitis A & B Vacc
Conditions: Hepatitis B;   Hepatitis A
Interventions: Biological: TWINRIX™;   Biological: Engerix™-B;   Biological: HAVRIX™;   Biological: HB VAX PRO™;   Biological: Vaqta™
15 Active, not recruiting A Study to Evaluate the Safety and Antiviral Effect of Multiple Doses of ABT-493 and ABT-530 in Adults With Genotype 1 Hepatitis C Virus (HCV)
Conditions: Chronic Hepatitis C;   Hepatitis C Virus;   Compensated Cirrhosis
Interventions: Drug: ABT-493;   Drug: ABT-530;   Drug: ABT-450/r/ABT-267;   Drug: ABT-333;   Drug: Ribavirin (RBV)
16 Completed
Has Results
Long-Term Immune Persistence of GSK Biologicals' Combined Hepatitis A & B Vaccine Injected According to a 0,1,6 Month Schedule
Conditions: Hepatitis B;   Hepatitis A
Intervention: Biological: Twinrix™ adult
17 Recruiting Vitamin D and Vitamin B12 Supplementation With Pegylated Interferon-Alfa Plus Ribavirin for Treating Chronic Hepatitis C
Conditions: RNA Virus Infections;   Flaviviridae Infections;   Hepatitis C;   Hepatitis C, Chronic
Interventions: Drug: Vitamin D;   Drug: Vitamin B 12
18 Recruiting A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Co-Administration of ABT-493 and ABT-530 With and Without RBV in Subjects With Chronic Hepatitis C Virus (HCV) Genotype 2 or Genotype 3 Infection
Conditions: Chronic Hepatitis C;   Hepatitis C Virus
Interventions: Drug: ABT-493;   Drug: ABT-530;   Drug: Ribavirin (RBV)
19 Not yet recruiting A Study to Evaluate the Safety and Efficacy of ABT-450/Ritonavir/ABT-267 and ABT-333 With Ribavirin in Adults With Genotype 1 Chronic Hepatitis C Virus Infection and Decompensated Cirrhosis
Conditions: Chronic Hepatitis C;   Decompensated Cirrhosis;   Hepatitis C Virus
Interventions: Drug: ABT-450/ritonavir/ABT-267;   Drug: ABT-333;   Drug: Ribavirin
20 Recruiting A Study to Evaluate the Safety and Efficacy of Ombitasvir/ABT-450/Ritonavir and Dasabuvir in Adults With Genotype 1b Chronic Hepatitis C Virus (HCV) Infection and Cirrhosis
Conditions: Chronic Hepatitis C Infection;   Compensated Cirrhosis;   Hepatitis C Virus
Interventions: Drug: ombitasvir/ABT-450/ritonavir;   Drug: dasabuvir

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years